Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
about
Enhanced anticancer activity of DM1-loaded star-shaped folate-core PLA-TPGS nanoparticlesCo-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.131I-Traced PLGA-Lipid Nanoparticles as Drug Delivery Carriers for the Targeted Chemotherapeutic Treatment of Melanoma.Self-assembling surfactant-like peptide A6K as potential delivery system for hydrophobic drugs.Folic acid-targeted disulfide-based cross-linking micelle for enhanced drug encapsulation stability and site-specific drug delivery against tumors.Effective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapyTumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancerTherapeutic and scintigraphic applications of polymeric micelles: combination of chemotherapy and radiotherapy in hepatocellular carcinomaCo-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.Interaction Mechanism of Doxorubicin and SWCNT: Protonation and Diameter Effects on the Drug Loading and Releasing.Recent advances of cocktail chemotherapy by combination drug delivery systems.Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy.Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer.Enhancing the anti-glioma therapy of doxorubicin by honokiol with biodegradable self-assembling micelles through multiple evaluations.Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers.Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment.Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer.Recent advances in amphiphilic polymers for simultaneous delivery of hydrophobic and hydrophilic drugs.Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy.Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells.Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.Methoxy poly (ethylene glycol)-block-poly (glutamic acid)-graft-6-(2-nitroimidazole) hexyl amine nanoparticles for potential hypoxia-responsive delivery of doxorubicin.Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy.Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect.Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivoCancer nanomedicine: progress, challenges and opportunities.Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancerApplication of a lipid-coated hollow calcium phosphate nanoparticle in synergistic co-delivery of doxorubicin and paclitaxel for the treatment of human lung cancer A549 cells.Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo.Synthetic polypeptides: from polymer design to supramolecular assembly and biomedical application.Co-Delivery of Drugs and Genes Using Polymeric Nanoparticles for Synergistic Cancer Therapeutic Effects.Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy.Ascorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapy.A multicomponent microemulsion using rational combination strategy improves lung cancer treatment through synergistic effects and deep tumor penetration.Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.Poly(ornithine-co-arginine-co-glycine-co-aspartic Acid): Preparation via NCA Polymerization and its Potential as a Polymeric Tumor-Penetrating Agent.Photocatalytic Degradation of Cell Membrane Coatings for Controlled Drug Release.Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
P2860
Q28654503-277E9AF4-6325-4134-A0DA-2A8C83BE3FD6Q33634653-57BAE3C3-7070-40D4-8165-3A9293F0E106Q33708363-6F9B5AAD-F376-4AE7-84BD-92ACCD74AB78Q35043759-A1D2C8F0-FDCF-494A-93FA-2485FF82C554Q35981477-77A36412-C835-44AA-A7C5-1801737F3A71Q35998388-9A366A51-4CD0-4320-9601-06F79F80FEF1Q36303474-79616E25-EB2C-419D-A563-8E7C0E39A5A5Q36394771-0F0638B9-B48A-4AF6-AFAE-45E5538835E1Q36561709-F3E11740-97BD-4F47-88F9-18F4A9C1A36AQ36617584-D81E6417-04B1-4A7B-8080-17ECF5D43E86Q37206908-A3FB9F00-FED9-45F2-9323-60B5BB015C04Q37249113-E20A8FEF-C769-4540-A233-4FD88886F940Q37626466-AED84E72-562A-4F95-8351-7FB5DDC8FF21Q37668174-FE6D2299-3599-44AC-B1D2-4B1A13E3D9A0Q37682912-9C8F17F6-1A11-43FF-B7DD-F3B9D13D3761Q37702449-4B58B3DD-E235-428C-B5A0-8D256C78CB80Q37714105-0AF30D0B-D8C4-47DD-891C-C6C39C08AF98Q38428931-07AD9047-68EC-46C4-9EAC-29970B00A6D2Q38664669-D8D8D7D8-97F8-4963-A35F-8CE9591BF2ADQ38664820-B182D969-A370-4551-8FCD-504C62824C72Q38698034-5601971A-AB76-47BF-B0FC-0910F7056990Q38809683-EA70F92D-E9C7-4079-ABDD-F8C4F048AD24Q38826097-74E2F0ED-4094-4472-91C7-B42070D74F94Q38836010-8D7A83E5-D7E6-4895-A6A9-9B5C0A6009ABQ38850079-4DAF6108-47F6-441D-BB8F-0CBDC6EC437FQ38863577-CDEE114F-04EC-43DA-8943-4CAA3EFBE384Q38867245-B7D34E30-F7F9-4252-8503-B75BE8B2890FQ39005226-0284BB80-D2B7-47E4-B0A6-CC9183A285ACQ41382500-F99AAD10-93AD-4871-A509-A58F8CC0524DQ45892685-B47C4730-9A6A-4698-812D-B2D710CCCE95Q47135282-93240F09-2835-4251-98F2-F826B71DACD3Q47638342-2293992C-CBAE-4B3C-8494-8D7479A78D13Q47642768-65CD8CB4-9618-45C3-8716-282CBD6A19F3Q47808831-3766732F-8277-4E2B-A396-F8DF8B6030DEQ48676428-91204E23-45F7-44F6-9B5E-776A3C9C2632Q48682294-BD5F3212-4BBC-41F3-AFEC-4FEC5F534BEDQ49714833-11459191-C968-462C-9F19-C560C27AD2D6Q50216858-A7357D8B-6966-4830-9ACE-9AF8F257906CQ50239784-D6D8221D-5FAA-4231-B40E-D725DE52D3ADQ50638687-42DA69B9-4912-44D6-A01D-63D2F11DB31B
P2860
Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Co-delivery of doxorubicin and ...... of non-small cell lung cancer.
@en
type
label
Co-delivery of doxorubicin and ...... of non-small cell lung cancer.
@en
prefLabel
Co-delivery of doxorubicin and ...... of non-small cell lung cancer.
@en
P2093
P1433
P1476
Co-delivery of doxorubicin and ...... of non-small cell lung cancer
@en
P2093
Huaiyu Liu
Shixian Lv
Wantong Song
Xuesi Chen
Yuanyuan Zhang
Yubin Huang
P304
P356
10.1016/J.BIOMATERIALS.2014.04.034
P577
2014-05-01T00:00:00Z